![Staff of the Department of Pathology and Molecular Diagnosis of Hadassah Tumors. Courtesy](https://nocamels.com/wp-content/uploads/2019/12/hadassa-350x263.jpg)
Hadassah Hospital 1st In Mideast To Use Unique Deep-Sequence Testing Of Tumor Tissue For Targeted Therapy
The test, called F1CDx, detects and identifies genetic changes in cancerous tumors such as substitutions, insertions, mutations, and alterations in 324 genes within a tissue sample.
December 09, 2019